The Board of Directors ('the Board') at its meeting held on 17th October, 2026 which commenced at 04:00 p.m. and concluded at 06:30 p.m., has approved and taken on record inter alia: a) The Un-audited Standalone Financial Results of the Company for the quarter and half year ended 30th September, 2026 prepared in terms of Regulation 33 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, along with Limited Review Report ....

HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 Date: 17th October, 2026 BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400 001 Dear Sir/Ma’am, Sub: Outcome of Board Meeting held today i.e., Saturday, 17th October, 2026 Ref: Scrip Code: 524590 | Symbol: HEMORGANIC | ISIN: INE422G01015 The Board of Directors (“the Board”) at its meeting held on 17th October, 2026 which commenced at 04:00 p.m. and concluded at 06:30 p.m., has approved and taken on record inter alia: a) The Un-audited Standalone Financial Results of the Company for the quarter and half year ended 30th September, 2026 prepared in terms of Regulation 33 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, along with Limited Review Report thereon submitted by the statutory auditors. b) To transact other businesses as per agenda being circulated. You are requested to take note of the above. Thanking You, Yours faithfully, For, Hemo Organic Limited Vishwambar Kameshwar Singh Managing Director DIN: 09822587